Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1247, 2000-01, pp. : 17-17
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
High-dose IFN- -2b improves survival in melanoma?
Inpharma, Vol. 1, Iss. 1249, 2000-01 ,pp. :
Access to resources
Recommend
Is There a Role for Adjuvant High-Dose Interferon- -2b in the Management of Melanoma?
Drugs, Vol. 63, Iss. 11, 2003-01 ,pp. :
Sargramostim: potential adjuvant therapy in melanoma?
Inpharma, Vol. 1, Iss. 1240, 2000-01 ,pp. :
PEG IFN- -2b + ribavirin: 24 weeks sufficient for HCV-2 and HCV-3?
Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. :
Lamivudine plus IFN- -2b: potential in hepatitis B?
Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. :